Orthomyxoviridae

This article is about the virus family that contains seven genera. For specific information about the subfamily that affects humans, see Influenza.

Orthomyxoviridae
Influenza A and influenza B viruses genome, mRNA, and virion diagram
Virus classification Edit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum: Negarnaviricota
Class: Insthoviricetes
Order: Articulavirales
Family: Orthomyxoviridae
Genera

See text

Orthomyxoviridae (from Ancient Greek ὀρθός (orthós) 'straight' and μύξα (mýxa) 'mucus')[1] is a family of negative-sense RNA viruses. It includes nine genera: Alphainfluenzavirus, Betainfluenzavirus, Gammainfluenzavirus, Deltainfluenzavirus, Isavirus, Mykissvirus, Quaranjavirus, Sardinovirus, and Thogotovirus. The first four genera contain viruses that cause influenza in birds (see also avian influenza) and mammals, including humans. Isaviruses infect salmon; the thogotoviruses are arboviruses, infecting vertebrates and invertebrates (such as ticks and mosquitoes).[2][3][4] The Quaranjaviruses are also arboviruses, infecting vertebrates (birds) and invertebrates (arthropods).

The four genera of Influenza virus that infect vertebrates, which are identified by antigenic differences in their nucleoprotein and matrix protein, are as follows:

Influenza A virus structure

The influenzavirus virion is pleomorphic; the viral envelope can occur in spherical and filamentous forms. In general, the virus's morphology is ellipsoidal with particles 100–120 nm in diameter, or filamentous with particles 80–100 nm in diameter and up to 20 μm long.[5] There are approximately 500 distinct spike-like surface projections in the envelope each projecting 10–14 nm from the surface with varying surface densities. The major glycoprotein (HA) spike is interposed irregularly by clusters of neuraminidase (NA) spikes, with a ratio of HA to NA of about 10 to 1.[6]

The viral envelope composed of a lipid bilayer membrane in which the glycoprotein spikes are anchored encloses the nucleocapsids; nucleoproteins of different sizes; the arrangement within the virion is uncertain. The ribonuclear proteins are filamentous and fall in the range of 50–150 nm long with helical symmetry.[7]

Illustration of influenza virus replication and genome. A) Replication and transcription of influenza A virus. B) Influenza A genome. C) Influenza B genome. D) Influenza C genome. Segments translate to polymerase (PB1, PB2, and PA), hemagglutinin (HA), neuramindase (NA), nucleoprotein (NP), membrane protein (M), and non-structural protein (NS).

Viruses of the family Orthomyxoviridae contain six to eight segments of linear negative-sense single stranded RNA. They have a total genome length that is 10,000–14,600 nucleotides (nt).[7] The influenza A genome, for instance, has eight pieces of segmented negative-sense RNA (13.5 kilobases total).[8]

The best-characterised of the influenzavirus proteins are hemagglutinin and neuraminidase, two large glycoproteins found on the outside of the viral particles. Hemagglutinin is a lectin that mediates binding of the virus to target cells and entry of the viral genome into the target cell.[9] In contrast, neuraminidase is an enzyme involved in the release of progeny virus from infected cells, by cleaving sugars that bind the mature viral particles. The hemagglutinin (H) and neuraminidase (N) proteins are key targets for antibodies and antiviral drugs,[10][11] and they are used to classify the different serotypes of influenza A viruses, hence the H and N in H5N1.

The genome sequence has terminal repeated sequences, and these are repeated at both ends (i.e., at both the 5' end and the 3' end). These terminal repeats at the 5′-end are 12–13 nucleotides long. Nucleotide sequences at the 3′-terminus are identical, are the same in genera of the same family, most on RNA (segments), or on all RNA species. Terminal repeats at the 3′-end are 9–11 nucleotides long. Encapsidated nucleic acid is solely genomic. Each virion may contain defective interfering copies. In Influenza A (specifically, in H1N1) PB1-F2 is produced from an alternative reading frame in PB1. The M and NS genes produce two genes each (4 genes total) via alternative splicing.[12]

Infection and replication of the influenza virus. The steps in this process are discussed in the text.

Typically, influenza is transmitted from infected mammals through the air by coughs or sneezes, creating aerosols containing the virus, and from infected birds through their droppings. Influenza can also be transmitted by saliva, nasal secretions, feces and blood. Infections occur through contact with these bodily fluids or with contaminated surfaces. On certain surfaces (i.e, outside of a host), flu viruses can remain infectious for about one week at human body temperature, over 30 days at 0 °C (32 °F), and indefinitely at very low temperatures (such as in lakes in northeast Siberia). They can be inactivated easily by disinfectants and detergents.[13][14][15]

The viruses interacts between its surface hemagglutinin glycoprotein to bind to the host's surface sialic acid sugars, specifically on the surfaces of epithelial cells in the lung and throat (Stage 1 in infection figure).[16] The cell imports the virus by endocytosis. In the acidic pH environment of the endosome, part of the hemagglutinin protein fuses the viral envelope with the vacuole's membrane, releasing: the viral RNA (vRNA) molecules, accessory proteins and RNA-dependent RNA polymerase into the host cell's cytoplasm (Stage 2).[17] These proteins and vRNA form a complex that is transported into the host cell nucleus, where the host's own RNA-dependent RNA polymerase begins transcribing complementary positive-sense cRNA (Steps 3a and b).[18] The cRNA is either exported into the cytoplasm and translated (step 4), or remains in the host nucleus. Newly synthesised viral proteins are either secreted through the Golgi apparatus onto the host cell surface (in the case of neuraminidase and hemagglutinin, step 5b) or transported into the host nucleus, where they bind vRNA and form new viral genome particles (step 5a). Other viral proteins have multiple actions in the host cell, including degrading cellular mRNA and using those consequently-released nucleotides for vRNA synthesis, while also inhibiting translation of the host cell's mRNAs.[19]

A virion assembles from negative-sense vRNAs (that form the genomes of newly created viruses), RNA-dependent RNA transcriptase and other viral proteins. Hemagglutinin and neuraminidase molecules cluster into a bulge in the host cell membrane. The vRNA and viral core proteins leave the nucleus and enter this membrane protrusion (step 6). The mature virus buds off from the host cell in a sphere of host phospholipid membrane, acquiring hemagglutinin and neuraminidase with this membrane coat (step 7).[20] As before, the viruses then adhere to the same host cell capsule through hemagglutinin; the mature viruses detach once their neuraminidase has cleaved sialic acid residues from the host cell.[16] After the release of new influenza virus, the host cell dies, and infection repeats in other host cells.

Transcription of mRNAs initiated by viral polymerase using cap snatching

Orthomyxoviridae viruses are one of two RNA viruses that replicate in the nucleus (the other being retroviridae). This is because the machinery of orthomyxo viruses cannot make their own mRNAs. They use cellular RNAs as primers for initiating the viral mRNA synthesis in a process known as cap snatching.[21] Once in the nucleus, the RNA Polymerase Protein PB2 finds a cellular pre-mRNA and binds to its 5′ capped end. Then RNA Polymerase PA cleaves off the cellular mRNA near the 5′ end and uses this capped fragment as a primer for transcribing the rest of the viral RNA genome in viral mRNA.[22] This is due to the need of mRNA to have a 5′ cap in order to be recognized by the cell's ribosome for translation.

Since RNA proofreading enzymes are absent, the RNA-dependent RNA transcriptase makes a single nucleotide insertion error roughly every 10 thousand nucleotides, which is the approximate length of the influenza vRNA. Hence, nearly every newly manufactured influenza virus will contain a mutation in its genome.[23] The separation of the genome into eight separate segments of vRNA allows mixing (reassortment) of the genes if more than one variety of influenza virus has infected the same cell (superinfection). The resulting alteration in the genome segments packaged into viral progeny confers new behavior, sometimes the ability to infect new host species or to overcome protective immunity of host populations to its old genome (in which case it is called an antigenic shift).[10]

In a phylogenetic-based taxonomy, RNA viruses include the subcategory negative-sense ssRNA virus, which includes the order Articulavirales, and the family Orthomyxoviridae. The family contains the following genera:[24]

There are four genera of influenza virus, each containing only a single species, or type. Influenza A and C infect a variety of species (including humans), while influenza B almost exclusively infects humans, and influenza D infects cattle and pigs.[25][26][27]

Diagram of influenza nomenclature

Influenza A viruses are further classified, based on the viral surface proteins hemagglutinin (HA or H) and neuraminidase (NA or N). 18 HA subtypes (or serotypes) and 11 NA subtypes of influenza A virus have been isolated in nature. Among these, the HA subtype 1-16 and NA subtype 1-9 are found in wild waterfowl and shorebirds and the HA subtypes 17-18 and NA subtypes 10-11 have only been isolated from bats.[28][29]

Further variation exists; thus, specific influenza strain isolates are identified by the Influenza virus nomenclature,[30] specifying virus type, host species (if not human), geographical location where first isolated, laboratory reference, year of isolation, and HA and NA subtype.[31][32]

Examples of the nomenclature are:

  1. A/Brisbane/59/2007 (H1N1) - isolated from a human
  2. A/swine/South Dakota/152B/2009 (H1N2) - isolated from a pig

The type A influenza viruses are the most virulent human pathogens among the three influenza types and cause the most severe disease. It is thought that all influenza A viruses causing outbreaks or pandemics originate from wild aquatic birds.[33] All influenza A virus pandemics since the 1900s were caused by Avian influenza, through Reassortment with other influenza strains, either those that affect humans (seasonal flu) or those affecting other animals (see 2009 swine flu pandemic).[34] The serotypes that have been confirmed in humans, ordered by the number of confirmed human deaths, are:

Known flu pandemics[10][39][40]
Name of pandemic Date Deaths Case fatality rate Subtype involved Pandemic Severity Index
1889–1890 flu pandemic
(Asiatic or Russian Flu)[41]
1889–1890 1 million 0.15% Possibly H3N8
or H2N2
N/a
1918 flu pandemic
(Spanish flu)[42]
1918–1920 20 to 100 million 2% H1N1 5
Asian Flu 1957–1958 1 to 1.5 million 0.13% H2N2 2
Hong Kong Flu 1968–1969 0.75 to 1 million <0.1% H3N2 2
Russian flu 1977–1978 No accurate count N/a H1N1 N/a
2009 flu pandemic[43][44] 2009–2010 105,700–395,600[45] 0.03% H1N1 N/A
Host range of influenza viruses

Influenza B virus is almost exclusively a human pathogen, and is less common than influenza A. The only other animal known to be susceptible to influenza B infection is the seal.[46] This type of influenza mutates at a rate 2–3 times lower than type A[47] and consequently is less genetically diverse, with only one influenza B serotype.[25] As a result of this lack of antigenic diversity, a degree of immunity to influenza B is usually acquired at an early age. However, influenza B mutates enough that lasting immunity is not possible.[33] This reduced rate of antigenic change, combined with its limited host range (inhibiting cross species antigenic shift), ensures that pandemics of influenza B do not occur.[48]

The influenza C virus infects humans and pigs, and can cause severe illness and local epidemics.[49] However, influenza C is less common than the other types and usually causes mild disease in children.[50][51]

This is a genus that was classified in 2016, the members of which were first isolated in 2011.[52] This genus appears to be most closely related to Influenza C, from which it diverged several hundred years ago.[53] There are at least two extant strains of this genus.[54] The main hosts appear to be cattle, but the virus has been known to infect pigs as well.

Evolution and history

[edit]

Genetic evolution of human and swine influenza viruses, 1918–2009

The predominant natural reservoir of influenza viruses is thought to be wild waterfowl.[55] A 2023 involving total RNA sequencing and transcriptome mining found that Influenzaviruses and the broader Articulavirales order likely had an aquatic origin, with fish being some of the earliest hosts, and the earliest viruses in the order evolving from Crustaceans over 600 million years ago.[56] The subtypes of influenza A virus are estimated to have diverged 2,000 years ago. Influenza viruses A and B are estimated to have diverged from a single ancestor around 4,000 years ago, while the ancestor of influenza viruses A and B and the ancestor of influenza virus C are estimated to have diverged from a common ancestor around 8,000 years ago.[57]

Outbreaks of influenza-like disease can be found throughout recorded history. The first probable record is by Hippocrates in 412 BCE.[58] The historian Fujikawa listed 46 epidemics of flu-like illness in Japan between 862 and 1868.[59] In Europe and the Americas, a number of epidemics were recorded through the Middle Ages and up to the end of the 19th century.[58]

Timeline of flu pandemics and epidemics caused by influenza A virus

In 1918–1919 came the first flu pandemic of the 20th century, known generally as the "Spanish flu", which caused an estimated 20 to 50 million deaths worldwide. It is now known that this was caused by an immunologically novel H1N1 subtype of influenza A.[60] The next pandemic took place in 1957, the "Asian flu", which was caused by a H2N2 subtype of the virus in which the genome segments coding for HA and NA appeared to have derived from avian influenza strains by reassortment, while the remainder of the genome was descended from the 1918 virus.[61] The 1968 pandemic ("Hong Kong flu") was caused by a H3N2 subtype in which the NA segment was derived from the 1957 virus, while the HA segment had been reassorted from an avian strain of influenza.[61]

In the 21st century, a strain of H1N1 flu (since titled "H1N1pdm09") was antigenically very different from previous H1N1 strains, leading to a pandemic in 2009. Because of its close resemblance to some strains circulating in pigs, this became known as "swine flu".[62]

Influenza A virus continues to circulate and evolve in birds and pigs. Almost all possible combinations of H (1 through 16) and N (1 through 11) have been isolated from wild birds.[63] As of June 2024, two particularly virulent IAV strains - H5N1 and H7N9 – are predominant in wild bird populations. These frequently cause outbreaks in domestic poultry, with occasional spillover infections in humans who are in close contact with poultry.[64][65]

Influenza viruses have a relatively high mutation rate that is characteristic of RNA viruses.[66] The segmentation of the influenza A virus genome facilitates genetic recombination by segment reassortment in hosts who become infected with two different strains of influenza viruses at the same time.[67][68] With reassortment between strains, an avian strain which does not affect humans may acquire characteristics from a different strain which enable it to infect and pass between humans – a zoonotic event.[69] It is thought that all influenza A viruses causing outbreaks or pandemics among humans since the 1900s originated from strains circulating in wild aquatic birds through reassortment with other influenza strains.[70][33] It is possible (though not certain) that pigs may act as an intermediate host for reassortment.[71]

The Global Influenza Surveillance and Response System (GISRS) is a global network of laboratories that monitor the spread of influenza with the aim to provide the World Health Organization with influenza control information and to inform vaccine development.[72] Several millions of specimens are tested by the GISRS network annually through a network of laboratories in 127 countries.[73] As well as human viruses, GISRS also monitors avian, swine, and other potentially zoonotic influenza viruses.

Seasonal variation in deaths due to influenza or pneumonia in 122 U.S. cities, as a proportion of all causes[74]

Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza, caused either by Influenza A or by Influenza B. The season occurs during the cold half of the year in temperate regions; November through February in the northern hemisphere and May to October in the southern hemisphere. Flu seasons also exist in the tropics and subtropics, with variability from region to region.[75] Annually, about 3 to 5 million cases of severe illness and 290,000 to 650,000 deaths from seasonal flu occur worldwide.[76]

There are several possible reasons for the winter peak in temperate regions:

  • During the winter, people spend more time indoors with the windows sealed, so they are more likely to breathe the same air as someone who has the flu and thus contract the virus.[77]
  • Days are shorter during the winter, and lack of sunlight leads to low levels of vitamin D and melatonin, both of which require sunlight for their generation. This compromises our immune systems, which in turn decreases ability to fight the virus.[77]
  • The influenza virus may survive better in colder, drier climates, and therefore be able to infect more people.[77]
  • Cold air reduces the ability of the nasal membranes to resist infection.[78]

Zoonotic infections

[edit]

A zoonosis is a disease in a human caused by a pathogen (such as a bacterium, or virus) that has jumped from a non-human to a human.[79][80] Avian and pig influenza viruses can, on rare occasions, transmit to humans and cause zoonotic influenza virus infections; these infections are usually confined to people who have been in close contact with infected animals or material such as infected feces and meat, they do not spread to other humans. Symptoms of these infections in humans vary greatly; some are in asymptomatic or mild while others can cause severe disease, leading to severe pneumonia and death.[81] A wide range of Influenza A virus subtypes have been found to cause zoonotic disease.[81][82]

Zoonotic infections can be prevented by good hygiene, by preventing farmed animals from coming into contact with wild animals, and by using appropriate personal protective equipment.[80]

As of June 2024, there is concern about two subtypes of avian influenza which are circulating in wild bird populations worldwide, H5N1 and H7N9. Both of these have potential to devastate poultry stocks, and both have jumped to humans with relatively high case fatality rates.[82] H5N1 in particular has infected a wide range of mammals and may be adapting to mammalian hosts.[83]

Symptoms of influenza,[84][85] with fever and cough the most common symptoms[86]

The symptoms of seasonal flu are similar to those of a cold, although usually more severe and less likely to include a runny nose.[87] The onset of symptoms is sudden, and initial symptoms are predominately non-specific: a sudden fever; muscle aches; cough; fatigue; sore throat; headache; difficulty sleeping; loss of appetite; diarrhoea or abdominal pain; nausea and vomiting.[88]

Humans can rarely become infected with strains of avian or swine influenza, usually as a result of close contact with infected animals or contaminated material; symptoms generally resemble seasonal flu but occasionally can be severe, including death.[89][90]

Some species of wild aquatic birds act as natural asymptomatic carriers of a large variety of influenza A viruses, which they can spread over large distances in their annual migration.[91] Symptoms of avian influenza vary according to both the strain of virus underlying the infection, and on the species of bird affected. Symptoms of influenza in birds may include swollen head, watery eyes, unresponsiveness, lack of coordination, respiratory distress such as sneezing or gurgling.[92]

Highly pathogenic avian influenza

[edit]

Because of the impact of avian influenza on economically important chicken farms, avian virus strains are classified as either highly pathogenic (and therefore potentially requiring vigorous control measures) or low pathogenic. The test for this is based solely on the effect on chickens - a virus strain is highly pathogenic avian influenza if 75% or more of chickens die after being deliberately infected with it, or if it is genetically similar to such a strain. The alternative classification is low pathogenic avian influenza.[93] Classification of a virus strain as either a low or high pathogenic strain is based on the severity of symptoms in domestic chickens and does not predict severity of symptoms in other species. Chickens infected with low pathogenic avian influenza display mild symptoms or are asymptomatic, whereas highly pathogenic avian influenza causes serious breathing difficulties, significant drop in egg production, and sudden death.[94]

Since 2006, the World Organization for Animal Health requires all detections of low pathogenic avian influenza H5 and H7 subtypes to be reported because of their potential to mutate into highly pathogenic strains.[95]

Signs of swine flu in pigs can include fever, depression, coughing (barking), discharge from the nose or eyes, sneezing, breathing difficulties, eye redness or inflammation, and going off feed. Some pigs infected with influenza, however, may show no signs of illness at all. Swine flu subtypes are principally H1N1, H1N2, and H3N2;[96] it is spread either through close contact between animals or by the movement of contaminated equipment between farms.[97] Humans who are in close contact with pigs can sometimes become infected.[98]

Equine influenza can affect horses, donkeys, and mules;[99] it has a very high rate of transmission among horses, and a relatively short incubation time of one to three days.[100] Clinical signs of equine influenza include fever, nasal discharge, have a dry, hacking cough, depression, loss of appetite and weakness.[100] EI is caused by two subtypes of influenza A viruses: H7N7 and H3N8, which have evolved from avian influenza A viruses.[101]

Most animals infected with canine influenza A will show symptoms such as coughing, runny nose, fever, lethargy, eye discharge, and a reduced appetite lasting anywhere from 2–3 weeks.[102] There are two different influenza A dog flu viruses: one is an H3N8 virus and the other is an H3N2 virus.[102] The H3N8 strain has evolved from an equine influenza avian virus which has adapted to sustained transmission among dogs. The H3N2 strain is derived from an avian influenza which jumped to dogs in 2004 in either Korea or China.[102] It is likely that the virus persists in both animal shelters and kennels, as well as in farms where dogs are raised for meat production.[103]

The first bat flu virus, IAV(H17N10), was first discovered in 2009 in little yellow-shouldered bats (Sturnira lilium) in Guatemala.[104] In 2012 a second bat influenza A virus IAV(H18N11) was discovered in flat-faced fruit-eating bats (Artibeus planirostris) from Peru.[105][106][107] Bat influenza viruses have been found to be poorly adapted to non-bat species.[108]

Viability and disinfection

[edit]

Mammalian influenza viruses tend to be labile, but they can survive several hours in a host's mucus.[109] Avian influenza virus can survive for 100 days in distilled water at room temperature and for 200 days at 17 °C (63 °F). The avian virus is inactivated more quickly in manure but can survive for up to two weeks in feces on cages. Avian influenza viruses can survive indefinitely when frozen.[109] Influenza viruses are susceptible to bleach, 70% ethanol, aldehydes, oxidizing agents and quaternary ammonium compounds. They are inactivated by heat at 133 °F (56 °C) for minimum of 60 minutes, as well as by low pH <2.[109]

Vaccination and prophylaxis

[edit]

Targets of anti-influenza agents that are licensed or under investigation

Vaccines and drugs are available for the prophylaxis and treatment of influenza virus infections. Vaccines are composed of either inactivated or live attenuated virions of the H1N1 and H3N2 human influenza A viruses, as well as those of influenza B viruses. Because the antigenicities of the wild viruses evolve, vaccines are reformulated annually by updating the seed strains.[110]

More specifically, flu vaccines are made using the reassortment method, and this has been used for over 50 years. In this method, scientists inject eggs with both one noninfectious flu strain and also one infectious strain. The inert strain must be one that multiples very well in chicken eggs. Scientists pick an infectious strain that carries the desired HA and N receptors that the final product should prevent from infection. They choose these strains by picking the surface HA and NA versions circulating the most in the public, and the ones thought most likely to be prevalent in the upcoming flu season. The two strains—pathogenic and non pathogenic—then multiply and exchange DNA until an inert strain carries eight copies of the infectious strain's two glycoprotein targets. Finally, of the newly created viruses, scientists pick six versions that multiplied the best in chicken eggs which also carry the necessary HA and NA genes. Ultimately, millions of eggs are injected with those noninfectious strains—which carry the desired proteins—so that the genes can be harvested and used for the vaccine product.[110]

Another method of making the vaccine is by splicing genes from infectious strains and then creating copies in a lab, without the need for the tedious process of chicken egg culture. This method relies on using virus plasmids to excerpt the target genes.[110]

When the antigenicities of the seed strains and wild viruses do not match, vaccines fail to protect the vaccines.[110]

Drugs available for the treatment of influenza include Amantadine and Rimantadine, which inhibit the uncoating of virions by interfering with M2 proton channel, and Oseltamivir (marketed under the brand name Tamiflu), Zanamivir, and Peramivir, which inhibit the release of virions from infected cells by interfering with NA. However, escape mutants are often generated for the former drug and less frequently for the latter drug.[111]

  1. ^ International Committee on Taxonomy of Viruses Index of Viruses — Orthomyxovirus (2006). In: ICTVdB—The Universal Virus Database, version 4. Büchen-Osmond, C (Ed), Columbia University, New York.
  2. ^ Jones LD, Nuttall PA (1989). "Non-viraemic transmission of Thogoto virus: influence of time and distance". Trans. R. Soc. Trop. Med. Hyg. 83 (5): 712–14. doi:10.1016/0035-9203(89)90405-7. PMID 2617637.
  3. ^ Ely B (1999). "Infectious Salmon Anaemia". Mill Hill Essays. National Institute for Medical Research. Archived from the original on 2007-08-24. Retrieved 2007-09-14.
  4. ^ Raynard RS, Murray AG, Gregory A (2001). "Infectious salmon anaemia virus in wild fish from Scotland". Dis. Aquat. Org. 46 (2): 93–100. Bibcode:2001DisAO..46...93R. doi:10.3354/dao046093. PMID 11678233.
  5. ^ Noda T (2012-01-03). "Native morphology of influenza virions". Frontiers in Microbiology. 2: 269. doi:10.3389/fmicb.2011.00269. PMC 3249889. PMID 22291683.
  6. ^ Einav T, Gentles LE, Bloom JD (2020-07-23). "SnapShot: Influenza by the Numbers" (PDF). Cell. 182 (2): 532–532.e1. doi:10.1016/j.cell.2020.05.004. PMID 32707094. S2CID 220715148.
  7. ^ a b "ICTV Ninth Report; 2009 Taxonomy Release: Orthomyxoviridae". ICTV. Retrieved 19 September 2020.
  8. ^ Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P, Dernovoy D, Tatusova T, Bao Y, St George K, Taylor J, Lipman DJ, Fraser CM, Taubenberger JK, Salzberg SL (October 2005). "Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution". Nature. 437 (7062): 1162–6. Bibcode:2005Natur.437.1162G. doi:10.1038/nature04239. PMID 16208317.
  9. ^ Suzuki Y (March 2005). "Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses". Biological & Pharmaceutical Bulletin. 28 (3): 399–408. doi:10.1248/bpb.28.399. PMID 15744059.
  10. ^ a b c Hilleman MR (August 2002). "Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control". Vaccine. 20 (25–26): 3068–87. doi:10.1016/S0264-410X(02)00254-2. PMID 12163258.
  11. ^ Wilson JC, von Itzstein M (July 2003). "Recent strategies in the search for new anti-influenza therapies". Current Drug Targets. 4 (5): 389–408. doi:10.2174/1389450033491019. PMID 12816348.
  12. ^ Bouvier NM, Palese P (September 2008). "The biology of influenza viruses". Vaccine. 26 (Suppl 4): D49–53. doi:10.1016/j.vaccine.2008.07.039. PMC 3074182. PMID 19230160.
  13. ^ Suarez DL, Spackman E, Senne DA, Bulaga L, Welsch AC, Froberg K (2003). "The effect of various disinfectants on detection of avian influenza virus by real time RT-PCR". Avian Diseases. 47 (3 Suppl): 1091–5. doi:10.1637/0005-2086-47.s3.1091. PMID 14575118. S2CID 8612187.
  14. ^ "Avian Influenza (Bird Flu) Implications for Human Disease. Physical characteristics of influenza A viruses". CIDRAP - Center for Infectious Disease Research and Policy. University of Minnesota. 12 March 2024.
  15. ^ "Flu viruses 'can live for decades' on ice". The New Zealand Herald. Reuters. November 30, 2006. Retrieved November 1, 2011.
  16. ^ a b Wagner R, Matrosovich M, Klenk H (May–Jun 2002). "Functional balance between haemagglutinin and neuraminidase in influenza virus infections". Rev Med Virol. 12 (3): 159–66. doi:10.1002/rmv.352. PMID 11987141. S2CID 30876482.
  17. ^ Lakadamyali M, Rust M, Babcock H, Zhuang X (Aug 5, 2003). "Visualizing infection of individual influenza viruses". Proc Natl Acad Sci USA. 100 (16): 9280–85. Bibcode:2003PNAS..100.9280L. doi:10.1073/pnas.0832269100. PMC 170909. PMID 12883000.
  18. ^ Cros J, Palese P (September 2003). "Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses". Virus Res. 95 (1–2): 3–12. doi:10.1016/S0168-1702(03)00159-X. PMID 12921991.
  19. ^ Kash J, Goodman A, Korth M, Katze M (July 2006). "Hijacking of the host-cell response and translational control during influenza virus infection". Virus Res. 119 (1): 111–20. doi:10.1016/j.virusres.2005.10.013. PMID 16630668.
  20. ^ Nayak D, Hui E, Barman S (December 2004). "Assembly and budding of influenza virus". Virus Res. 106 (2): 147–65. doi:10.1016/j.virusres.2004.08.012. PMC 7172797. PMID 15567494.
  21. ^ "Cap Snatching". ViralZone. expasy. Retrieved 11 September 2014.
  22. ^ Dias A, Bouvier D, Crépin T, McCarthy AA, Hart DJ, Baudin F, Cusack S, Ruigrok RW (April 2009). "The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit". Nature. 458 (7240): 914–8. Bibcode:2009Natur.458..914D. doi:10.1038/nature07745. PMID 19194459. S2CID 4421958.
  23. ^ Drake J (May 1, 1993). "Rates of spontaneous mutation among RNA viruses". Proc Natl Acad Sci USA. 90 (9): 4171–5. Bibcode:1993PNAS...90.4171D. doi:10.1073/pnas.90.9.4171. PMC 46468. PMID 8387212.
  24. ^ "Virus Taxonomy: 2024 Release". International Committee on Taxonomy of Viruses. Retrieved 19 March 2025.
  25. ^ a b Hay A, Gregory V, Douglas A, Lin Y (Dec 29, 2001). "The evolution of human influenza viruses". Philos Trans R Soc Lond B Biol Sci. 356 (1416): 1861–70. doi:10.1098/rstb.2001.0999. PMC 1088562. PMID 11779385.
  26. ^ "Avian Influenza (Bird Flu)". Centers for Disease Control and Prevention. Retrieved 2007-09-15.
  27. ^ Kumar, Binod; Asha, Kumari; Khanna, Madhu; Ronsard, Larance; Meseko, Clement Adebajo; Sanicas, Melvin (April 2018). "The emerging influenza virus threat: status and new prospects for its therapy and control". Archives of Virology. 163 (4): 831–844. doi:10.1007/s00705-018-3708-y. ISSN 1432-8798. PMC 7087104. PMID 29322273.
  28. ^ Alexander, Dennis J. (2007-07-26). "An overview of the epidemiology of avian influenza". Vaccine. 25 (30): 5637–5644. doi:10.1016/j.vaccine.2006.10.051. ISSN 0264-410X. PMID 17126960.
  29. ^ Wu, Ying; Wu, Yan; Tefsen, Boris; Shi, Yi; Gao, George F. (April 2014). "Bat-derived influenza-like viruses H17N10 and H18N11". Trends in Microbiology. 22 (4): 183–191. doi:10.1016/j.tim.2014.01.010. ISSN 0966-842X. PMC 7127364. PMID 24582528.
  30. ^ "A revision of the system of nomenclature for influenza viruses: a WHO Memorandum". Bull World Health Organ. 58 (4): 585–591. 1980. PMC 2395936. PMID 6969132. This Memorandum was drafted by the signatories listed on page 590 on the occasion of a meeting held in Geneva in February 1980.
  31. ^ Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. (2007). Epidemiology and Prevention of Vaccine-Preventable Diseases (10th ed.). Washington DC: Centers for Disease Control and Prevention.
  32. ^ "Avian Influenza (Bird Flu): Implications for Human Disease". Center for Infectious Disease Research & Policy, University of Minnesota. 2007-06-27. Retrieved 2007-09-14.
  33. ^ a b c Webster, R. G.; Bean, W. J.; Gorman, O. T.; Chambers, T. M.; Kawaoka, Y. (March 1992). "Evolution and ecology of influenza A viruses". Microbiological Reviews. 56 (1): 152–179. Bibcode:1992MbRev..56..152W. doi:10.1128/mr.56.1.152-179.1992. ISSN 0146-0749. PMC 372859. PMID 1579108.
  34. ^ Taubenberger, Jeffery K.; Morens, David M. (April 2010). "Influenza: the once and future pandemic". Public Health Reports. 125 (Suppl 3): 16–26. doi:10.1177/00333549101250S305. ISSN 0033-3549. PMC 2862331. PMID 20568566.
  35. ^ Wang TT, Palese P (June 2009). "Unraveling the Mystery of Swine Influenza Virus". Cell. 137 (6): 983–85. doi:10.1016/j.cell.2009.05.032. PMID 19524497.
  36. ^ Taubenberger, JK, Morens, DM (April 2009). "Pandemic influenza – including a risk assessment of H5N1". Rev. Sci. Tech. Off. Int. Epiz. 28 (1): 187–202. doi:10.20506/rst.28.1.1879. PMC 2720801. PMID 19618626.
  37. ^ Fouchier R, Schneeberger P, Rozendaal F, Broekman J, Kemink S, Munster V, Kuiken T, Rimmelzwaan G, Schutten M, Van Doornum G, Koch G, Bosman A, Koopmans M, Osterhaus A (2004). "Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome". Proc Natl Acad Sci USA. 101 (5): 1356–61. Bibcode:2004PNAS..101.1356F. doi:10.1073/pnas.0308352100. PMC 337057. PMID 14745020.
  38. ^ Malik-Peiris JS, Poon LL, Guan Y (July 2009). "Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans". J Clin Virol. 45 (3): 169–173. doi:10.1016/j.jcv.2009.06.006. PMC 4894826. PMID 19540800.
  39. ^ Potter CW (October 2001). "A history of influenza". Journal of Applied Microbiology. 91 (4): 572–9. Bibcode:2001JApMb..91..572P. doi:10.1046/j.1365-2672.2001.01492.x. PMID 11576290. S2CID 26392163.
  40. ^ "Ten things you need to know about pandemic influenza". World Health Organization. 14 October 2005. Archived from the original on 23 September 2009. Retrieved 26 September 2009.
  41. ^ Valleron AJ, Cori A, Valtat S, Meurisse S, Carrat F, Boëlle PY (May 2010). "Transmissibility and geographic spread of the 1889 influenza pandemic". Proc. Natl. Acad. Sci. USA. 107 (19): 8778–81. Bibcode:2010PNAS..107.8778V. doi:10.1073/pnas.1000886107. PMC 2889325. PMID 20421481.
  42. ^ Mills CE, Robins JM, Lipsitch M (December 2004). "Transmissibility of 1918 pandemic influenza". Nature. 432 (7019): 904–06. Bibcode:2004Natur.432..904M. doi:10.1038/nature03063. PMC 7095078. PMID 15602562.
  43. ^ Donaldson LJ, Rutter PD, Ellis BM, et al. (2009). "Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study". BMJ. 339 b5213. doi:10.1136/bmj.b5213. PMC 2791802. PMID 20007665.
  44. ^ "ECDC Daily Update – Pandemic (H1N1) 2009 – January 18, 2010" (PDF). European Centre for Disease Prevention and Control. 2010-01-18. Archived from the original (PDF) on January 22, 2010. Retrieved 2010-01-18.
  45. ^ Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, Mølbak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu H, Vong S, Bresee J, Widdowson MA (September 2012). "Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study". The Lancet. Infectious Diseases (Submitted manuscript). 12 (9): 687–95. Bibcode:2012LanID..12..687D. doi:10.1016/S1473-3099(12)70121-4. PMID 22738893. Archived (PDF) from the original on Apr 9, 2024 – via Zenodo.
  46. ^ Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA (May 2000). "Influenza B virus in seals". Science. 288 (5468): 1051–3. Bibcode:2000Sci...288.1051O. doi:10.1126/science.288.5468.1051. PMID 10807575.
  47. ^ Nobusawa E, Sato K (April 2006). "Comparison of the mutation rates of human influenza A and B viruses". Journal of Virology. 80 (7): 3675–8. doi:10.1128/JVI.80.7.3675-3678.2006. PMC 1440390. PMID 16537638.
  48. ^ Zambon MC (November 1999). "Epidemiology and pathogenesis of influenza". The Journal of Antimicrobial Chemotherapy. 44 Suppl B (Suppl B): 3–9. doi:10.1093/jac/44.suppl_2.3. PMID 10877456. S2CID 15968981.
  49. ^ Matsuzaki Y, Sugawara K, Mizuta K, Tsuchiya E, Muraki Y, Hongo S, Suzuki H, Nakamura K (2002). "Antigenic and genetic characterization of influenza C viruses which caused two outbreaks in Yamagata City, Japan, in 1996 and 1998". J Clin Microbiol. 40 (2): 422–29. doi:10.1128/JCM.40.2.422-429.2002. PMC 153379. PMID 11825952.
  50. ^ Matsuzaki Y, Katsushima N, Nagai Y, Shoji M, Itagaki T, Sakamoto M, Kitaoka S, Mizuta K, Nishimura H (May 1, 2006). "Clinical features of influenza C virus infection in children". J Infect Dis. 193 (9): 1229–35. doi:10.1086/502973. PMID 16586359.
  51. ^ Katagiri S, Ohizumi A, Homma M (July 1983). "An outbreak of type C influenza in a children's home". J Infect Dis. 148 (1): 51–56. doi:10.1093/infdis/148.1.51. PMID 6309999.
  52. ^ Hause BM, Ducatez M, Collin EA, Ran Z, Liu R, Sheng Z, Armien A, Kaplan B, Chakravarty S, Hoppe AD, Webby RJ, Simonson RR, Li F (February 2013). "Isolation of a novel swine influenza virus from Oklahoma in 2011 which is distantly related to human influenza C viruses". PLOS Pathogens. 9 (2) e1003176. doi:10.1371/journal.ppat.1003176. PMC 3567177. PMID 23408893.
  53. ^ Sheng Z, Ran Z, Wang D, Hoppe AD, Simonson R, Chakravarty S, Hause BM, Li F (February 2014). "Genomic and evolutionary characterization of a novel influenza-C-like virus from swine". Archives of Virology. 159 (2): 249–55. doi:10.1007/s00705-013-1815-3. PMC 5714291. PMID 23942954.
  54. ^ Collin EA, Sheng Z, Lang Y, Ma W, Hause BM, Li F (January 2015). "Cocirculation of two distinct genetic and antigenic lineages of proposed influenza D virus in cattle". Journal of Virology. 89 (2): 1036–42. doi:10.1128/JVI.02718-14. PMC 4300623. PMID 25355894.
  55. ^ Mahmoud SM, Alison M, Knobler SL, eds. (2005). "1, The Story of Influenza.". The Threat of Pandemic Influenza: Are We Ready? Workshop Summary. Institute of Medicine (US) Forum on Microbial Threats. Washington (DC): National Academies Press (US).
  56. ^ Mary E. Petrone; Rhys Parry; Jonathon C. O. Mifsud; Kate Van Brussel; Ian Vorhees; Zoe T. Richards; Edward C. Holmes (16 February 2023). "Evidence for an aquatic origin of influenza virus and the order Articulavirales". bioRxiv 10.1101/2023.02.15.528772.
  57. ^ Suzuki Y, Nei M (April 2002). "Origin and evolution of influenza virus hemagglutinin genes". Molecular Biology and Evolution. 19 (4). Ocford Academic: 501–509. doi:10.1093/oxfordjournals.molbev.a004105. PMID 11919291.
  58. ^ a b "The History of Influenza". www.flu.com. Retrieved 20 June 2024.
  59. ^ Shimizu K (October 1997). "[History of influenza epidemics and discovery of influenza virus]". Nihon Rinsho. Japanese Journal of Clinical Medicine. 55 (10): 2505–2511. PMID 9360364.
  60. ^ "CDC Archives: 1918 Pandemic (H1N1 virus)". U.S. Centers for Disease Control and Prevention (CDC). 20 March 2019. Retrieved 20 June 2024.
  61. ^ a b Knobler SL, Mack A, Mahmoud A, Lemon SM, et al. (Institute of Medicine (US) Forum on Microbial Threats) (2005). "The Story of Influenza". The Threat of Pandemic Influenza: Are We Ready? Workshop Summary. National Academies Press (US). Retrieved 20 June 2024.
  62. ^ "2009 H1N1 Pandemic (H1N1pdm09 virus)". CU.S. Centers for Disease Control and Prevention (CDC). 11 June 2019. Retrieved 21 June 2024.
  63. ^ "FluGlobalNet – Avian Influenza". science.vla.gov.uk. Retrieved 5 June 2024.
  64. ^ "The next pandemic: H5N1 and H7N9 influenza?". Gavi, the Vaccine Alliance. 26 March 2021. Retrieved 21 June 2024.
  65. ^ "Influenza (Avian and other zoonotic)". World Health Organization. 3 October 2023. Retrieved 21 June 2024.
  66. ^ Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R (October 2010). "Viral mutation rates". Journal of Virology. 84 (19): 9733–9748. Bibcode:2010JVir...84.9733S. doi:10.1128/JVI.00694-10. PMC 2937809. PMID 20660197.
  67. ^ Kou Z, Lei FM, Yu J, Fan ZJ, Yin ZH, Jia CX, Xiong KJ, Sun YH, Zhang XW, Wu XM, Gao XB, Li TX (December 2005). "New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China". Journal of Virology. 79 (24): 15460–15466. doi:10.1128/JVI.79.24.15460-15466.2005. PMC 1316012. PMID 16306617.
  68. ^ "Evolution of H5N1 avian influenza viruses in Asia". Emerging Infectious Diseases. 11 (10): 1515–1521. October 2005. doi:10.3201/eid1110.050644. PMC 3366754. PMID 16318689. Figure 1 shows a diagramatic representation of the genetic relatedness of Asian H5N1 hemagglutinin genes from various isolates of the virus
  69. ^ "Transmission of Bird Flu Viruses Between Animals and People". U.S. Centers for Disease Control and Prevention (CDC). 15 May 2024. Retrieved 10 June 2024.
  70. ^ Taubenberger JK, Morens DM (April 2010). "Influenza: the once and future pandemic". Public Health Reports. 125 (Suppl 3): 16–26. doi:10.1177/00333549101250S305. PMC 2862331. PMID 20568566.
  71. ^ "Factsheet on swine influenza in humans and pigs". European Centre for Disease Control. 15 June 2017. Retrieved 13 June 2024.
  72. ^ Lee K, Fang J (2013). Historical Dictionary of the World Health Organization. Rowman & Littlefield. ISBN 978-0-8108-7858-7.
  73. ^ "70 years of GISRS – the Global Influenza Surveillance & Response System". World Health Organization. 19 September 2022. Retrieved 13 June 2024.
  74. ^ CDC U.S. influenza season summary with weekly updates See section 'Pneumonia and Influenza (P&I) Mortality Surveillance' www.cdc.gov, accessed 30 September 2020
  75. ^ Hirve S, Newman LP, Paget J, Azziz-Baumgartner E, Fitzner J, Bhat N, Vandemaele K, Zhang W (27 April 2016). "Influenza Seasonality in the Tropics and Subtropics – When to Vaccinate?". PLOS ONE. 11 (4) e0153003. Bibcode:2016PLoSO..1153003H. doi:10.1371/journal.pone.0153003. PMC 4847850. PMID 27119988.
  76. ^ "Influenza (Seasonal)". World Health Organization. Retrieved 22 June 2024.
  77. ^ a b c "The Reason for the Season: why flu strikes in winter". Science in the News, a Graduate Student Group at the Harvard Graduate School of the Arts and Sciences. 1 December 2014. Retrieved 21 June 2024.
  78. ^ LaMotte S (6 December 2022). "Scientists finally know why people get more colds and flu in winter". CNN. Retrieved 21 June 2024.
  79. ^ "zoonosis". Merriam-Webster.com Dictionary. Merriam-Webster. OCLC 1032680871. Retrieved 29 March 2019.
  80. ^ a b "Zoonoses - Key Facts". World Health Organization. 29 July 2020. Retrieved 24 June 2024.
  81. ^ a b "Zoonotic influenza - Annual Epidemiological Report for 2022". www.ecdc.europa.eu. 23 May 2023. Retrieved 24 June 2024.
  82. ^ a b "Global AIV with Zoonotic Potential". The Food and Agriculture Organization (FAO) of the United Nations. 29 July 2020. Retrieved 24 June 2024.
  83. ^ Plaza PI, Gamarra-Toledo V, Euguí JR, Lambertucci SA (March 2024). "Recent Changes in Patterns of Mammal Infection with Highly Pathogenic Avian Influenza A(H5N1) Virus Worldwide". Emerging Infectious Diseases. 30 (3): 444–452. doi:10.3201/eid3003.231098. PMC 10902543. PMID 38407173.
  84. ^ "Flu Symptoms & Diagnosis". U.S. Centers for Disease Control and Prevention (CDC). 10 July 2019. Archived from the original on 27 December 2019. Retrieved 24 January 2020.
  85. ^ "Flu Symptoms & Complications". U.S. Centers for Disease Control and Prevention. 26 February 2019. Archived from the original on 1 August 2020. Retrieved 6 July 2019.
  86. ^ Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP (February 2005). "Does this patient have influenza?". JAMA. 293 (8): 987–997. doi:10.1001/jama.293.8.987. PMID 15728170.
  87. ^ "Cold Versus Flu". U.S. Centers for Disease Control and Prevention (CDC). 29 September 2022. Retrieved 25 June 2024.
  88. ^ "Flu". National Health Service UK. 9 August 2023. Retrieved 25 June 2024.
  89. ^ "Avian influenza: guidance, data and analysis". GOV.UK. 18 November 2021. Retrieved 9 May 2024.
  90. ^ "Swine influenza in humans". European Centre for Disease Prevention and Control (ECDC). 20 September 2017. Retrieved 17 June 2024.
  91. ^ "Bird flu (avian influenza): how to spot and report it in poultry or other captive birds". Department for Environment, Food & Rural Affairs and Animal and Plant Health Agency. 13 December 2022. Retrieved 6 May 2024.
  92. ^ "Avian flu". The Royal Society for the Protection of Birds (RSPB). Retrieved 25 June 2024.
  93. ^ Alexander DJ, Brown IH (April 2009). "History of highly pathogenic avian influenza". Revue Scientifique et Technique. 28 (1): 19–38. doi:10.20506/rst.28.1.1856. PMID 19618616.
  94. ^ "Avian Influenza in Birds". U.S. Centers for Disease Control and Prevention (CDC). 14 June 2022. Retrieved 6 May 2024.
  95. ^ "National H5/H7 Avian Influenza surveillance plan". United States Department of Agriculture. Animal Plant Health Inspection Service. October 2013.
  96. ^ "Factsheet on swine influenza in humans and pigs". European Centre for Disease Prevention and Control. 15 June 2017. Retrieved 25 June 2024.
  97. ^ "Key Facts about Swine Influenza (Swine Flu) in Pigs". U.S. Centers for Disease Control and Prevention (CDC). 3 October 2018. Retrieved 25 June 2024.
  98. ^ "2023: outbreaks of swine influenza". World Health Organization. 30 March 2024. Retrieved 25 June 2024.
  99. ^ "Equine influenza". WOAH – World Organisation for Animal Health. Retrieved 25 June 2024.
  100. ^ a b "Equine Influenza: Respiratory Diseases of Horses: Merck Veterinary Manual". www.merckvetmanual.com. Archived from the original on 15 November 2016. Retrieved 4 December 2016.
  101. ^ "Horse Flu". U.S. Centers for Disease Control and Prevention (CDC). 5 May 2023. Retrieved 25 June 2024.
  102. ^ a b c "Key Facts about Canine Influenza (Dog Flu)". U.S. Centers for Disease Control and Prevention (CDC). 29 August 2023. Retrieved 25 June 2024.
  103. ^ Wasik BR, Voorhees IE, Parrish CR (January 2021). "Canine and Feline Influenza". Cold Spring Harbor Perspectives in Medicine. 11 (1) a038562. doi:10.1101/cshperspect.a038562. PMC 7778219. PMID 31871238.
  104. ^ "Bat Influenza (Flu)". cdc.gov. 10 July 2024. Retrieved 23 March 2025.
  105. ^ "Characterization of bat influenza viruses". uniklinik-freiburg.de. Retrieved 30 June 2020.
  106. ^ "New flu virus found in bats". Nature. 503 (7475): 169. 2013. doi:10.1038/503169e. Retrieved 30 June 2020.
  107. ^ Ciminski K, Pfaff F, Beer M, Schwemmle M (April 2020). "Bats reveal the true power of influenza A virus adaptability". PLOS Pathogens. 16 (4) e1008384. doi:10.1371/journal.ppat.1008384. PMC 7161946. PMID 32298389.
  108. ^ Ciminski K, Ran W, Gorka M, Lee J, Malmlov A, Schinköthe J, Eckley M, Murrieta RA, Aboellail TA, Campbell CL, Ebel GD, Ma J, Pohlmann A, Franzke K, Ulrich R, Hoffmann D, García-Sastre A, Ma W, Schountz T, Beer M, Schwemmle M (December 2019). "Bat influenza viruses transmit among bats but are poorly adapted to non-bat species". Nature Microbiology. 4 (12): 2298–2309. doi:10.1038/s41564-019-0556-9. PMC 7758811. PMID 31527796. S2CID 202580293.
  109. ^ a b c Spickler AR (February 2016). "Influenza" (PDF). The Center for Food Security and Public Health. Iowa State University. p. 7.
  110. ^ a b c d Hood, Ernie (2006). "Flu Vaccine Production Gets a Shot in the Arm". Environmental Health Perspectives. 114 (2): A108–A111. doi:10.1289/ehp.114-a108 (inactive 26 January 2026). PMC 1367863. PMID 16451835.{{cite journal}}: CS1 maint: DOI inactive as of January 2026 (link)
  111. ^ Suzuki Y (October 2006). "Natural selection on the influenza virus genome". Molecular Biology and Evolution. 23 (10). Oxford Academic: 1902–11. doi:10.1093/molbev/msl050. PMID 16818477. Archived from the original on Jan 21, 2022.